Lessons Learned: Adapting Research during the Pandemic

Please join the Health and Behavior Research Affinity Group for a panel discussion.

Naomi Goldstein, PhD, is Professor of Psychology at Drexel University, Co-Director of Drexel’s JD/PhD Program in Law and Psychology, and a Stoneleigh Foundation Fellow. An applied researcher and Director of the Juvenile Justice Research and Reform Lab at Drexel, Goldstein seeks to improve juvenile justice policy and practice to promote positive outcomes for youth. For the past 15 years, her work has focused on adolescents’ capacities to make legal decisions, their abilities to fulfill behavioral requirements of the law, and the development of juvenile justice interventions and procedures to promote youths’ long-term well-being.

Katherine Bevans, PhD, is a child health outcomes methodologist whose work is grounded in the belief that stakeholder engagement enhances the value and impact of health outcomes research. Dr. Bevans has developed and validated more than a dozen child- and parent-report health outcome measurement tools. She supported the creation of 22 Patient Reported Outcome Measurement Information System® (PROMIS) pediatric item banks including measures of children’s stress response, subjective wellbeing, physical activity, family relationships, and global health. These instruments are used to gauge the quality of pediatric healthcare in research, quality monitoring and improvement, and clinical care contexts.

Matthew Hocking, PhD, is a pediatric psychologist in the Cancer Center and the Center for Childhood Cancer Research. Dr. Hocking’s Research Program bridges the fields of neuropsychology, developmental, pediatric and family psychology and examines risk and resilience factors associated with the neurodevelopmental outcomes of youth diagnosed with brain tumors, solid tumors, and neurofibromatosis. Primary neurodevelopmental outcomes of interest include neurocognitive and social functioning. Dr. Hocking also is involved in developing and testing interventions to improve neurodevelopmental outcomes of survivors. The ultimate goal of his research is to enhance the functional outcomes and overall quality of life for survivors and their families.